Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-11.66 Insider Own0.20% Shs Outstand333.33M Perf Week-3.82%
Market Cap74.66B Forward P/E12.46 EPS next Y17.98 Insider Trans-9.73% Shs Float330.76M Perf Month-10.07%
Income-3981.80M PEG- EPS next Q4.18 Inst Own88.20% Short Float1.65% Perf Quarter2.22%
Sales15.07B P/S4.96 EPS this Y63.30% Inst Trans0.41% Short Ratio2.65 Perf Half Y-9.44%
Book/sh209.70 P/B1.07 EPS next Y10.52% ROA8.90% Target Price275.44 Perf Year-11.44%
Cash/sh17.48 P/C12.82 EPS next 5Y13.42% ROE15.70% 52W Range184.50 - 256.80 Perf YTD6.66%
Dividend2.80 P/FCF293.14 EPS past 5Y-28.70% ROI0.10% 52W High-12.78% Beta1.20
Dividend %1.25% Quick Ratio1.10 Sales past 5Y26.00% Gross Margin87.10% 52W Low21.40% ATR4.09
Employees16700 Current Ratio1.20 Sales Q/Q8.80% Oper. Margin-20.80% RSI (14)19.11 Volatility1.58% 1.75%
OptionableYes Debt/Eq0.43 EPS Q/Q-88.00% Profit Margin77.30% Rel Volume0.97 Prev Close224.77
ShortableYes LT Debt/Eq0.38 EarningsAug 03 BMO Payout5.00% Avg Volume2.07M Price223.99
Recom2.10 SMA20-8.03% SMA50-7.58% SMA200-1.61% Volume2,003,763 Change-0.35%
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Aug-18-17 10:50PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) GlobeNewswire
07:10PM  Allergan Plc Value Analysis (NYSE:AGN) : August 18, 2017 Capital Cube
07:09PM  Cramers Exec Cut: The huge millennial influence on moder... CNBC Videos
Aug-16-17 05:18PM  Shire Files Marketing Application for Lifitegrast in Europe Zacks
05:16PM  Black, Jewish Goldman Sachs executive sues firm for discr... CNBC Videos
03:03PM  Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices TheStreet.com
02:17PM  Black, Jewish Goldman Sachs exec sues firm for discrimination over Allergan CEO client bid CNBC
08:00AM  Allergan to Present at the 2017 Wells Fargo Healthcare Conference PR Newswire
Aug-15-17 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) PR Newswire
11:18AM  [$$] Merck, Allergan, Lilly: Top Pharma Picks Barrons.com
07:36AM  Pfizers Declining-Revenue Products in 2Q17 Market Realist
06:00AM  Shire applies for European approval of potential blockbuster eye drop American City Business Journals
Aug-14-17 03:42PM  Big-name U.S. hedge funds shed healthcare stocks during the rally in Q2 Reuters
09:38AM  Jim Cramer Says Allergan Shares Are 'Just Too Cheap' TheStreet.com
09:11AM  Why Jim Cramer Likes Allergan TheStreet.com
08:03AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Aug-12-17 10:31AM  Edited Transcript of AGN earnings conference call or presentation 3-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
08:02AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Aug-11-17 10:50PM  ALLERGAN SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Allergan, Inc. - (AGN) Business Wire
11:38AM  [$$] Drug industry faces 'tidal wave' of litigation over opioid crisis Financial Times
10:27AM  More than half of women who got an abortion last year were using contraception MarketWatch
08:03AM  See what the IHS Markit Score report has to say about Allergan plc. Markit
Aug-10-17 08:30PM  AGN: Rosen Law Firm Reminds Allergan, Inc. Investors of Important Deadline in Class Action AGN GlobeNewswire
Aug-09-17 05:21PM  Teva Plunges to 10-Year Low, Credit Rating in Jeopardy Zacks
10:02AM  Drugmaker Teva looks to sell Medis business to help cut debt Reuters
Aug-08-17 10:50PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) PR Newswire
01:59PM  As Drug Overdoses Hit Record High, Trump Offers Little on Opioid Policy Fortune
09:16AM  Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 8, 2017 Capital Cube
08:04AM  Allergan's Brent Saunders Is Charging Into Medical Aesthetics. Should Others Follow? Forbes
06:39AM  Allergan: Cramer's Top Takeaways TheStreet.com
Aug-07-17 07:24PM  Allergan CEO: More millennials and men turn to aesthetic ... CNBC Videos
07:01PM  Cramer Remix: This tech stock was one of the greatest bar... CNBC Videos
06:59PM  Cramer Remix: This tech stock was one of the greatest bargains of all time CNBC
06:40PM  Allergan CEO sees more millennials and men turning to aes... CNBC Videos
06:22PM  Allergan CEO sees more millennials and men turning to aesthetic medical treatments CNBC
12:13PM  Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire TheStreet.com
11:55AM  Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing Benzinga
08:00AM  FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years PR Newswire
07:00AM  Corporate News Blog - Mallinckrodt to Acquire InfaCare Pharmaceutical and its Developmental Product Stannsoporfin ACCESSWIRE
Aug-04-17 10:50PM  ALLERGAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) GlobeNewswire
02:12PM  Analysts Still Like Allergan Benzinga
10:40AM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Not a Falling Knife, Its a Guillotine InvestorPlace
10:20AM  Ironwood (IRWD) Q2 Loss Widens, Revenues Miss, Stock Up Zacks
09:43AM  Lilly's acute migraine drug succeeds in late-stage study Reuters
02:28AM  Allergan reports 2Q loss Associated Press
Aug-03-17 08:00PM  Dow Stretches Record-Making Streak Into Day Seven With Small Gains TheStreet.com
07:01PM  Cramer: This Bull Will Gore You Without a Thought TheStreet.com
04:00PM  Why Allergan Is Stagnant Despite Beating Views, Raising Outlook Investor's Business Daily
03:16PM  Allergan Posts Better-Than-Expected Second Quarter Earnings TheStreet.com
03:15PM  Allergan Just Can't Break Through Despite a Ton of Positive Catalysts at Its Back TheStreet.com
02:35PM  Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone Motley Fool
02:09PM  2 factors driving the generics market: Wells Fargo Securi... CNBC Videos
10:50AM  Allergan (AGN) Q2 Earnings & Sales Top, Restasis Sales Down Zacks
10:15AM  Dow Tries to Hold in the Green, but Rest of Market Slides TheStreet.com
09:59AM  Three Large Cap Pharma Picks That Can Outperform This Year Barrons.com
09:37AM  Allergan (AGN) Beats Q2 Earnings & Sales; Shares Down Zacks
08:39AM  Botox-maker Allergan's quarterly profit beats estimates Reuters
08:35AM  Wall Street set to open flat after Dow breaks 22,000; jobless claims in focus CNBC
08:28AM  Allergan reports Q2 profit, revenue beats MarketWatch
08:10AM  Botox-maker Allergan quarterly revenue rises 9 pct Reuters
07:51AM  Allergan Reports Continued Strong Execution in Second Quarter 2017 with 9% Increase in GAAP Net Revenues to $4.0 Billion PR Newswire
06:15AM  Investor Network: Allergan plc to Host Earnings Call ACCESSWIRE
Aug-02-17 05:02PM  5 Stocks that are Earnings All-Stars Zacks
10:10AM  Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2 Zacks
08:00AM  Allergan Announces Third Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share PR Newswire
Aug-01-17 10:50PM  Allergan Shareholder Alert by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) Marketwired
07:31PM  Hedge Funds' Favorite Health Care Stocks Reporting Earnings This Week GuruFocus.com
01:19PM  [$$] Pfizer Waiting for Cues on Tax Reform to Pursue Deals The Wall Street Journal
Jul-31-17 02:30PM  3 Dividend Stocks That Outperform the Big Techs Investopedia
12:20PM  Pfizer Inc. (PFE) Stock Isnt the Sexiest, But its Worth Checking Out InvestorPlace
10:48AM  Allergan (AGN) to Report Q2 Earnings: What's in the Cards? Zacks
09:00AM  Amgen And Allergan Submit Biosimilar Biologics License Application For ABP 980 To US Food And Drug Administration PR Newswire
Jul-28-17 10:50PM  ALLERGAN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Allergan, Inc. - (AGN) GlobeNewswire
09:24PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. AGN GlobeNewswire
Jul-27-17 03:38PM  U.S. Senator expands opioid probe to distributors, drugmakers Reuters
10:05AM  [$$] McCaskill Expands Probe Into Opioid Addiction Crisis The Wall Street Journal
Jul-24-17 05:22PM  Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Allergan, Inc. - AGN Accesswire
Jul-22-17 10:00AM  Trump Could Still Unleash an Attack on Amazon Real Soon, Doug Kass Says TheStreet.com
Jul-17-17 11:30AM  Valeant Unloads Yet Another Unit Barrons.com
10:37AM  Inside Allergans International Business Market Realist
09:06AM  How Allergans US General Medicines Segment Performed Market Realist
07:37AM  How Allergans US Specialized Therapeutics Segment Performed Market Realist
Jul-14-17 10:37AM  Behind Allergans Business Segments and Revenues Market Realist
09:09AM  Understanding Allergans Revenue Stream for 2017 Market Realist
07:40AM  What Allergans Valuation as of July 13 Tells Us Market Realist
Jul-13-17 06:59PM  Cramer: Mea culpa! This stock's action is why I say small... CNBC Videos
05:33PM  Inside Allergans Developments in 2Q17 Market Realist
09:00AM  Allergan Lends Support to Broaden Uterine Fibroid Awareness Month PR Newswire
08:00AM  Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab) PR Newswire
Jul-11-17 04:29PM  Allergan Reports Positive New Data on Irritable Bowl Drug Zacks
03:12PM  As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals TheStreet.com
08:07AM  See America Furthers The Fight Against Preventable Blindness With #EyePic Campaign PR Newswire
07:36AM  A Look at Allergans Performance in 2Q17 Market Realist
Jul-10-17 10:30AM  Allergan Reports New Data Reinforcing the Effectiveness of Viberzi® (Eluxadoline) to Treat the Symptoms Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D), Abdominal Pain and Diarrhea PR Newswire
Jul-07-17 04:30PM  Allergan, Celgene Offer Solid Biotech Value TheStreet.com
04:19PM  AGN NOTICE: Rosen Law Firm Reminds Allergan, Inc. Investors of Important Deadline in Class Action Business Wire
03:51PM  US Pharmaceuticals: Mergers and Acquisitions in 2Q17 Market Realist
01:30PM  Allergan, Celgene Offer Solid Biotech Value TheStreet.com
10:05AM  UK Supreme Court rules in Eli Lilly's favor in drug dispute Associated Press
10:02AM  UK Supreme Court Rules in Lilly's Favor: Actavis Infringed on European Vitamins Patents TheStreet.com
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, the company distributes generic and branded pharmaceutical products primarily to independent and chain pharmacies, nursing homes, mail order pharmacies, hospitals, clinics, and physician offices. Further, it develops a portfolio of breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. The company has licensing agreement with Assembly Biosciences, Inc.; Mimetogen Pharmaceuticals, Inc.; Almirall, S.A; Naurex, Inc.; and Merck & Co. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Basgoz NesliDirectorMay 18Option Exercise84.441,889159,5077,919May 22 04:26 PM
Basgoz NesliDirectorMay 18Sale220.451,889416,4306,030May 22 04:26 PM
GALLAGHER MICHAEL RDirectorMay 04Option Exercise245.2517,6934,339,20820,272May 05 06:34 PM
BISARO PAULDirectorMar 02Sale246.6870,00017,267,561235,900Mar 06 06:59 AM
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM